DYADIC INTERNATIONAL INC APIC, Share-based Payment Arrangement, Increase for Cost Recognition
DYADIC INTERNATIONAL INC (DYAI) reported APIC, Share-based Payment Arrangement, Increase for Cost Recognition of $144.37 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-12.
Financial Statements › Shareholders' Equity
us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue · last filed 2026-08-12
- DYADIC INTERNATIONAL INC apic, share-based payment arrangement, increase for cost recognition for the quarter ending 2026-06-30 was $144.37K, a 57.60% decline year-over-year.
- DYADIC INTERNATIONAL INC apic, share-based payment arrangement, increase for cost recognition for the quarter ending 2026-03-31 was $139.30K, a 38.10% decline year-over-year.
- DYADIC INTERNATIONAL INC apic, share-based payment arrangement, increase for cost recognition for the quarter ending 2025-09-30 was $172.35K, a 30.33% decline year-over-year.
- DYADIC INTERNATIONAL INC apic, share-based payment arrangement, increase for cost recognition for the quarter ending 2025-06-30 was $340.46K, a 14.40% increase year-over-year.
- DYADIC INTERNATIONAL INC apic, share-based payment arrangement, increase for cost recognition for fiscal 2025 was $930.18K, a 17.41% decline from fiscal 2024.
- DYADIC INTERNATIONAL INC apic, share-based payment arrangement, increase for cost recognition for fiscal 2024 was $1.13M, a 9.47% decline from fiscal 2023.
- DYADIC INTERNATIONAL INC apic, share-based payment arrangement, increase for cost recognition for fiscal 2023 was $1.24M, a 34.14% decline from fiscal 2022.
- DYADIC INTERNATIONAL INC apic, share-based payment arrangement, increase for cost recognition for fiscal 2022 was $1.89M, a 5.88% increase from fiscal 2021.
| Period end | APIC, Share-based Payment Arrangement, Increase for Cost Recognition 3 month | APIC, Share-based Payment Arrangement, Increase for Cost Recognition 3 month as first filed | APIC, Share-based Payment Arrangement, Increase for Cost Recognition 6 month | APIC, Share-based Payment Arrangement, Increase for Cost Recognition 9 month | APIC, Share-based Payment Arrangement, Increase for Cost Recognition 12 month |
|---|---|---|---|---|---|
| 2026-06-30 | $144.37K 10-Q · filed 2026-08-12 | $283.67K derived: sum of 2 quarters · filed 2026-08-12 | |||
| 2026-03-31 | $139.30K 10-Q · filed 2026-08-12 | ||||
| 2025-12-31 | $930.18K 10-K · filed 2026-03-25 | ||||
| 2025-09-30 | $172.35K 10-Q · filed 2025-11-12 | $512.81K derived: sum of 2 quarters · filed 2026-08-12 | $737.84K derived: sum of 3 quarters · filed 2026-08-12 | ||
| 2025-06-30 | $340.46K 10-Q · filed 2026-08-12 | $565.49K derived: sum of 2 quarters · filed 2026-08-12 | |||
| 2025-03-31 | $225.03K 10-Q · filed 2026-08-12 | ||||
| 2024-12-31 | $1.13M 10-K · filed 2026-03-25 | ||||
| 2024-09-30 | $247.39K 10-Q · filed 2025-11-12 | $544.99K derived: sum of 2 quarters · filed 2025-11-12 | $851.47K derived: sum of 3 quarters · filed 2025-11-12 | ||
| 2024-06-30 | $297.60K 10-Q · filed 2025-11-12 | $604.08K derived: sum of 2 quarters · filed 2025-11-12 | |||
| 2024-03-31 | $306.48K 10-Q · filed 2025-11-12 | ||||
| 2023-12-31 | $1.24M 10-K · filed 2025-03-26 | ||||
| 2023-09-30 | $281.31K 10-Q · filed 2023-11-08 | $615.62K derived: sum of 2 quarters · filed 2024-11-12 | $946.26K derived: sum of 3 quarters · filed 2024-11-12 | ||
| 2023-06-30 | $334.32K 10-Q · filed 2024-11-12 | $664.96K derived: sum of 2 quarters · filed 2024-11-12 | |||
| 2023-03-31 | $330.64K 10-Q · filed 2024-11-12 | ||||
| 2022-12-31 | $1.89M 10-K · filed 2024-03-28 | ||||
| 2022-09-30 | $499.92K 10-Q · filed 2023-11-08 | $954.42K derived: sum of 2 quarters · filed 2023-11-08 | $1.41M derived: sum of 3 quarters · filed 2023-11-08 | ||
| 2022-06-30 | $454.50K 10-Q · filed 2023-11-08 | $908.29K derived: sum of 2 quarters · filed 2023-11-08 | |||
| 2022-03-31 | $453.79K 10-Q · filed 2023-11-08 | $453.79M 10-Q · filed 2022-05-12 | |||
| 2021-12-31 | $1.78M 10-K · filed 2023-03-29 | ||||
| 2021-09-30 | $457.21K 10-Q · filed 2022-11-10 | $903.33K derived: sum of 2 quarters · filed 2022-11-10 | $1.32M derived: sum of 3 quarters · filed 2022-11-10 | $1.71M derived: sum of 4 quarters · filed 2022-11-10 | |
| 2021-06-30 | $446.12K 10-Q · filed 2022-11-10 | $867.19K derived: sum of 2 quarters · filed 2022-11-10 | $1.25M derived: sum of 3 quarters · filed 2022-11-10 | $1.66M derived: sum of 4 quarters · filed 2022-11-10 | |
| 2021-03-31 | $421.07K 10-Q · filed 2022-11-10 | $808.73K derived: sum of 2 quarters · filed 2022-11-10 | $1.21M derived: sum of 3 quarters · filed 2022-11-10 | $1.65M derived: sum of 4 quarters · filed 2022-11-10 | |
| 2020-12-31 | $387.66K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-29 | $788.34K derived: sum of 2 quarters · filed 2022-03-29 | $1.22M derived: sum of 3 quarters · filed 2022-03-29 | $1.65M 10-K · filed 2022-03-29 | |
| 2020-09-30 | $400.68K 10-Q · filed 2021-11-10 | $837.29K derived: sum of 2 quarters · filed 2021-11-10 | $1.26M 10-Q · filed 2020-11-12 | $1.40M derived: sum of 4 quarters · filed 2021-11-10 | |
| 2020-06-30 | $436.61K 10-Q · filed 2021-11-10 | $863.55K 10-Q · filed 2020-08-13 | $1.00M derived: sum of 3 quarters · filed 2021-11-10 | $1.14M derived: sum of 4 quarters · filed 2021-11-10 | |
| 2020-03-31 | $426.94K 10-Q · filed 2021-11-10 | $563.67K derived: sum of 2 quarters · filed 2021-11-10 | $707.85K derived: sum of 3 quarters · filed 2021-11-10 | $1.29M derived: sum of 4 quarters · filed 2021-11-10 | |
| 2019-12-31 | $136.73K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-30 | $280.91K derived: sum of 2 quarters · filed 2021-03-30 | $861.52K derived: sum of 3 quarters · filed 2021-03-30 | $1.17M 10-K · filed 2021-03-30 | |
| 2019-09-30 | $144.18K 10-Q · filed 2020-11-12 | $724.78K derived: sum of 2 quarters · filed 2020-11-12 | $1.03M 10-Q · filed 2019-11-13 | ||
| 2019-06-30 | $580.60K 10-Q · filed 2020-11-12 | $890.17K 10-Q · filed 2019-08-13 | |||
| 2019-03-31 | $309.56K 10-Q · filed 2020-11-12 | ||||
| 2018-12-31 | $467.20K 10-K · filed 2020-03-30 | ||||
| 2018-09-30 | $70.62K 10-Q · filed 2019-11-13 | $144.04K derived: sum of 2 quarters · filed 2019-11-13 | $413.64K derived: sum of 3 quarters · filed 2019-11-13 | ||
| 2018-06-30 | $73.42K 10-Q · filed 2019-11-13 | $343.02K derived: sum of 2 quarters · filed 2019-11-13 | |||
| 2018-03-31 | $269.60K 10-Q · filed 2019-11-13 | ||||
| 2017-12-31 | $643.43K 10-K · filed 2019-03-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| BioCardia, Inc. (BCDA) | United States | $0.016B | |
| Passage BIO, Inc. (PASG) | United States | $0.015B | -0.43 |
| Pluri Inc. (PLUR) | $0.014B | ||
| INTENSITY THERAPEUTICS, INC. (INTS) | United States | $0.013B | -1.08 |
| BRAINSTORM CELL THERAPEUTICS INC. (BCLI) | United States | $0.013B | -1.05 |
| Jasper Therapeutics, Inc. (JSPR) | United States | $0.020B | -0.37 |
| IN8BIO, INC. (INAB) | United States | $0.012B | -0.76 |
| Estrella Immunopharma, Inc. (ESLA) | United States | $0.020B | |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |